FREMONT, Calif., March 10 /PRNewswire-FirstCall/ -- Vermillion, Inc. (VRML.PK) today announced the appointment of its distinguished Scientific Advisory Board to assist in directing the Company's product development strategies. Members of the scientific advisory board are distinguished members of academia and industry with experience in diagnostic test development and commercialization. The SAB will be chaired by Eric Fung, MD, PhD, Senior Vice President and Chief Scientific Officer.
The scientific advisory board is composed of the following individuals:
--Walter Carney, PhD, is Head of the Oncogene Science organization, which functions as a center of Oncology Excellence for Siemens Dx. Previously, Dr. Carney was President of Oncogene Science and Corporate Officer for OSI Pharmaceuticals and also held the position of Vice President of Proprietary Drug Development. In addition to being the inventor of the circulating HER-2/neu protein test, Dr Carney has been a leader in integrating the FDA cleared test into the clinical management of women with HER-2 positive breast cancer. Dr Carney was also the first to discover and patent monoclonal antibodies to ras oncoprotein mutations. Dr. Carney has published over 250 articles and abstracts, has been awarded over 25 patents and has numerous pending patent applications. Dr. Carney received his Ph.D. in Medical Microbiology and Infectious Diseases from Thomas Jefferson Medical School in Philadelphia, PA.
-- John P. Cooke, MD. PhD, is Professor and Associate Director of the Stanford Cardiovascular Institute at Stanford University School of Medicine. He directs a translational program in vascular regeneration. The research group utilizes molecular and cellular strategies to gain new insights into mechanisms of vascular disease, and employs pre-clinical models to test new therapies and diagnostic strategies directed toward peripheral arterial disease. These insights are applied by the group in clinical studies of patients with intermittent claudication or critical limb ischemia. Dr. Cooke is a founder and Past President of the Society for Vascular Medicine, and an author of over 350 scientific articles in vascular medicine and biology. Dr. Cooke trained in Cardiology and Vascular Medicine at the Mayo Clinic, and was a member of the professoriate at Harvard Medical School before his recruitment to Stanford.
About Vermillion:
Forward Looking Statement:
CONTACT: Jill Totenberg, The Totenberg Group, +1-212-994-7363,
jt@totenberggroup.com
Web site: http://www.vermillion.com/
